Cytotoxic B Cells in Relapsing-Remitting Multiple Sclerosis Patients

BACKGROUND: Emerging evidence of antibody-independent functions, as well as the clinical efficacy of anti-CD20 depleting therapies, helped to reassess the contribution of B cells during multiple sclerosis (MS) pathogenesis. OBJECTIVE: To investigate whether CD19(+) B cells may share expression of th...

Descripción completa

Detalles Bibliográficos
Autores principales: Boldrini, Vinícius O., Marques, Ana M., Quintiliano, Raphael P. S., Moraes, Adriel S., Stella, Carla R. A. V., Longhini, Ana Leda F., Santos, Irene, Andrade, Marília, Ferrari, Breno, Damasceno, Alfredo, Carneiro, Rafael P. D., Brandão, Carlos Otávio, Farias, Alessandro S., Santos, Leonilda M. B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8859463/
https://www.ncbi.nlm.nih.gov/pubmed/35197967
http://dx.doi.org/10.3389/fimmu.2022.750660

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8859463/
https://www.ncbi.nlm.nih.gov/pubmed/35197967
http://dx.doi.org/10.3389/fimmu.2022.750660

Ejemplares similares